Inge Stegeman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Inge Stegeman has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
Patrick M. Bossuyt
6 shared publications- Paul Fockens
Gastroenterology and Hepatology, Academic Medical Center, Amsterdam, Netherlands
5 shared publications Esther M. Stoop
4 shared publications- Evelien Dekker
Cancer Center Amsterdam, Amsterdam, The Netherlands
4 shared publications - Roderik A. Kraaijenhagen
NDDO Institute for Prevention and Early Diagnostics (NIPED), Amsterdam, The Netherlands
4 shared publications - Ernst J. Kuipers
Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center, Rotterdam, The Netherlands
3 shared publications
Latest Publications
- 1 June 2013
- Published by Elsevier in Cancer Epidemiology
- Vol. 37 (3) , 278-283
Colorectal cancer risk factors in the detection of advanced adenoma and colorectal cancer
- 1 June 2013
- Published by Elsevier in Cancer Epidemiology
- Vol. 37 (3) , 278-283
Colorectal cancer risk factors in the detection of advanced adenoma and colorectal cancer
- 1 May 2013
- Published by Elsevier in Gastroenterology
- Vol. 144 (5)
Mo1187 Can Endoscopists Correctly Predict Polyp Histopathology in FIT Based Screening?
- 1 May 2013
- Published by Elsevier in Gastroenterology
- Vol. 144 (5)
Mo1187 Can Endoscopists Correctly Predict Polyp Histopathology in FIT Based Screening?
- 1 October 2012
- Published by Elsevier in Cancer Epidemiology
- Vol. 36 (5) , 461-469
Cancer risk models and preselection for screening
- 1 October 2012
- Published by Elsevier in Cancer Epidemiology
- Vol. 36 (5) , 461-469
Cancer risk models and preselection for screening
- Open Access
- 19 June 2012
- Published by Springer Nature in BMC Gastroenterology
- Vol. 12 (1) , 73
Implementation of population screening for colorectal cancer by repeated Fecal Immunochemical Test (FIT): third round
Colorectal cancer (CRC) is the most common cancer in Europe with a mortality rate of almost 50%. The prognosis of patients is largely determined by the clinical and pathological stage at the time of diagnosis. Population screening has been shown to reduce CRC-related mortality rate. Most screening programs worldwide rely on fecal immunochemical testing (FIT). The effectiveness of a FIT screening program is not only influenced by initial participation rate, but also by program adherence during consecutive screening rounds. We aim to evaluate the participation rate in and yield of a third CRC screening round using FIT. Four years after the first screening round and two years after the second round, a total number of approximately 11,000 average risk individuals (50 to 75 years of age) will be invited to participate in a third round of FIT-based CRC screening. We will select individuals in the same target area as in the previous screening rounds, using the electronic database of the regional municipal administration registrations. We will invite all FIT-negatives and all non-participants in previous screening rounds, as well as eligible first time invitees who have moved into the area or have become 50 years of age. FITs will be analyzed in the special technique laboratory of the Academic Medical Center of the University of Amsterdam. All FIT-positives will be invited for a consultation at the outpatient clinic. In the absence of contra-indications, a colonoscopy will follow at the Academic Medical Center or at the Flevohospital. The primary outcome measures are the participation rate, defined as the proportion of invitees that return a FIT in this third round of FIT-screening, and the diagnostic yield of the program. This study will provide precise data on the participation in later FIT screening rounds. This enables to estimate the effectiveness of CRC screening programs that rely on repeated FIT- screening, such as the one that will be implemented in the Netherlands in 2013.
- 19 June 2012
- Published by Springer Nature in BMC Gastroenterology
- Vol. 12 (1) , 73
Open AccessImplementation of population screening for colorectal cancer by repeated Fecal Immunochemical Test (FIT): third round
Colorectal cancer (CRC) is the most common cancer in Europe with a mortality rate of almost 50%. The prognosis of patients is largely determined by the clinical and pathological stage at the time of diagnosis. Population screening has been shown to reduce CRC-related mortality rate. Most screening programs worldwide rely on fecal immunochemical testing (FIT). The effectiveness of a FIT screening program is not only influenced by initial participation rate, but also by program adherence during consecutive screening rounds. We aim to evaluate the participation rate in and yield of a third CRC screening round using FIT. Four years after the first screening round and two years after the second round, a total number of approximately 11,000 average risk individuals (50 to 75 years of age) will be invited to participate in a third round of FIT-based CRC screening. We will select individuals in the same target area as in the previous screening rounds, using the electronic database of the regional municipal administration registrations. We will invite all FIT-negatives and all non-participants in previous screening rounds, as well as eligible first time invitees who have moved into the area or have become 50 years of age. FITs will be analyzed in the special technique laboratory of the Academic Medical Center of the University of Amsterdam. All FIT-positives will be invited for a consultation at the outpatient clinic. In the absence of contra-indications, a colonoscopy will follow at the Academic Medical Center or at the Flevohospital. The primary outcome measures are the participation rate, defined as the proportion of invitees that return a FIT in this third round of FIT-screening, and the diagnostic yield of the program. This study will provide precise data on the participation in later FIT screening rounds. This enables to estimate the effectiveness of CRC screening programs that rely on repeated FIT- screening, such as the one that will be implemented in the Netherlands in 2013.
- 1 May 2012
- Published by Elsevier in Gastroenterology
- Vol. 142 (5)
Tu1205 Higher Risk of a False Negative Fecal Immunochemical Testing (FIT) Result in Smokers and in Higher Age Groups
- 1 May 2012
- Published by Elsevier in Gastroenterology
- Vol. 142 (5)
Tu1205 Higher Risk of a False Negative Fecal Immunochemical Testing (FIT) Result in Smokers and in Higher Age Groups
- 1 May 2011
- Published by Elsevier in Gastroenterology
- Vol. 140 (5)
The Diagnostic Value of Risk Factors in Population Screening for Colorectal Cancer
- 1 May 2011
- Published by Elsevier in Gastroenterology
- Vol. 140 (5)
The Diagnostic Value of Risk Factors in Population Screening for Colorectal Cancer
- 1 May 2011
- Published by Elsevier in Gastroenterology
- Vol. 140 (5)
Can an Individual Risk Profile for CRC Be Used as Triage Test in CRC Screening
- 1 May 2011
- Published by Elsevier in Gastroenterology
- Vol. 140 (5)
Can an Individual Risk Profile for CRC Be Used as Triage Test in CRC Screening
- 1 January 2010
- Vol. 154, A1906
[Integrated risk profiling allows prevention and early intervention].
Prevention and early intervention can alter the course and incidence of several chronic diseases. Integrated risk profiling is based on the fact that a single risk factor affects more than one condition. Integrated risk profiling uses these overlapping risk factors to calculate the risks of a number of conditions. When used in screening, these risks can be communicated to participants, providing feedback and helping them understand the conditions they are at risk of, eventually leading to better compliance with preventive and therapeutic interventions. In this paper we discuss the underlying principles and background of the rise in integrated risk profiling in public health. We demonstrate why the attractive concept of risk profiling needs further assessment to estimate its effectiveness relative to other methods of prevention, population screening and case finding.
- 1 January 2010
- Vol. 154, A1906
[Integrated risk profiling allows prevention and early intervention].
Prevention and early intervention can alter the course and incidence of several chronic diseases. Integrated risk profiling is based on the fact that a single risk factor affects more than one condition. Integrated risk profiling uses these overlapping risk factors to calculate the risks of a number of conditions. When used in screening, these risks can be communicated to participants, providing feedback and helping them understand the conditions they are at risk of, eventually leading to better compliance with preventive and therapeutic interventions. In this paper we discuss the underlying principles and background of the rise in integrated risk profiling in public health. We demonstrate why the attractive concept of risk profiling needs further assessment to estimate its effectiveness relative to other methods of prevention, population screening and case finding.